Abstract
BackgroundIn rheumatic diseases, quantitative assessment including estimates of global status by physicians (DOCGL) and patients (PATGL) is required since there is no any single gold standard biomarker measure for optimal...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
